HCA Healthcare Inc. (NYSE: HCA) is -7.64% lower on its value in year-to-date trading and has touched a low of $164.47 and a high of $279.02 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The HCA stock was last observed hovering at around $234.74 in the last trading session, with the day’s gains setting it 2.54% off its average median price target of $239.00 for the next 12 months. It is also 16.16% off the consensus price target high of $283.00 offered by 26 analysts, but current levels are -58.19% lower than the price target low of $150.00 for the same period.
Currently trading at $237.28, the stock is 7.34% and 13.61% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.97 million and changing 1.08% at the moment leaves the stock 9.36% off its SMA200. HCA registered -1.82% loss for a year compared to 6-month gain of 15.10%.
The stock witnessed a 10.67% loss in the last 1 month and extending the period to 3 months gives it a 11.11%, and is 2.72% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.88% over the week and 2.63% over the month.
HCA Healthcare Inc. (HCA) has around 204000 employees, a market worth around $66.27B and $59.80B in sales. Current P/E ratio is 13.40 and Fwd P/E is 13.03. Profit margin for the company is 9.00%. Distance from 52-week low is 44.27% and -14.96% from its 52-week high. The company has generated returns on investments over the last 12 months (22.50%).
HCA Healthcare Inc. (HCA) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for HCA Healthcare Inc. (HCA) is a “Overweight”. 26 analysts offering their recommendations for the stock have an average rating of 1.80, where 5 rate it as a Hold and 3 think it is a “Overweight”. 18 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
HCA Healthcare Inc. is expected to release its quarterly report on 01/31/2023.The EPS is expected to grow by 93.70% this year
HCA Healthcare Inc. (HCA) Top Institutional Holders
The shares outstanding are 285.96M, and float is at 210.77M with Short Float at 1.61%.
HCA Healthcare Inc. (HCA) Insider Activity
A total of 18 insider transactions have happened at HCA Healthcare Inc. (HCA) in the last six months, with sales accounting for 12 and purchases happening 6 times. The most recent transaction is an insider sale by MOORE A BRUCE JR, the company’s Group President – Service Line. SEC filings show that MOORE A BRUCE JR sold 10,000 shares of the company’s common stock on Nov 11 at a price of $224.07 per share for a total of $2.24 million. Following the sale, the insider now owns 30807.0 shares.
HCA Healthcare Inc. disclosed in a document filed with the SEC on Oct 28 that Hall Charles J (Group President) sold a total of 9,838 shares of the company’s common stock. The trade occurred on Oct 28 and was made at $223.50 per share for $2.2 million. Following the transaction, the insider now directly holds 0.2 million shares of the HCA stock.
Still, SEC filings show that on Oct 28, Sowell Joseph A III (SVP; Chief Development Officer) disposed off 12,946 shares at an average price of $223.18 for $2.89 million. The insider now directly holds 0 shares of HCA Healthcare Inc. (HCA).
HCA Healthcare Inc. (HCA): Who are the competitors?
The company’s main competitors (and peers) include Community Health Systems Inc. (CYH) that is trading -76.26% down over the past 12 months and Tenet Healthcare Corporation (THC) that is -43.31% lower over the same period. Universal Health Services Inc. (UHS) is -0.23% down on the 1-year trading charts.